Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice - PubMed (original) (raw)
Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice
D Zeng et al. J Immunol. 2000.
Abstract
Since anti-CD1 TCR transgenic T cells can activate syngeneic B cells via CD1 to secrete IgM and IgG and induce lupus in BALB/c mice, we studied the role of CD1 in the pathogenesis of lupus in NZB/NZW mice. Approximately 20% of B cells from the spleens of NZB/NZW mice expressed high levels of CD1 (CD1high B cells). The latter subset spontaneously produced large amounts of IgM anti-dsDNA Abs in vitro that was up to 25-fold higher than that of residual CD1int/low B cells. T cells in the NZB/NZW spleen proliferated vigorously to the CD1-transfected A20 B cell line, but not to the parent line. Treatment of NZB/NZW mice with anti-CD1 mAbs ameliorated the development of lupus. These results suggest that the CD1high B cells and their progeny are a major source of autoantibody production, and activation of B cells via CD1 may play an important role in the pathogenesis of lupus.
Similar articles
- Separation of the New Zealand Black genetic contribution to lupus from New Zealand Black determined expansions of marginal zone B and B1a cells.
Atencio S, Amano H, Izui S, Kotzin BL. Atencio S, et al. J Immunol. 2004 Apr 1;172(7):4159-66. doi: 10.4049/jimmunol.172.7.4159. J Immunol. 2004. PMID: 15034028 - Natural killer T cells and innate immune B cells from lupus-prone NZB/W mice interact to generate IgM and IgG autoantibodies.
Takahashi T, Strober S. Takahashi T, et al. Eur J Immunol. 2008 Jan;38(1):156-65. doi: 10.1002/eji.200737656. Eur J Immunol. 2008. PMID: 18050273 Free PMC article. - [Fc receptor redux: the role of immunoglobulin receptor (FcR) in glomerulonephritis].
Ra C, Suzuki Y. Ra C, et al. Nihon Naika Gakkai Zasshi. 1998 Aug 10;87(8):1568-76. doi: 10.2169/naika.87.1568. Nihon Naika Gakkai Zasshi. 1998. PMID: 9780689 Review. Japanese. No abstract available.
Cited by
- Expansion of invariant natural killer T cells from systemic lupus erythematosus patients by alpha-Galactosylceramide and IL-15.
Hsu CY, Chueh YS, Kuo ML, Lee PT, Hsiao HS, Huang JL, Lin SJ. Hsu CY, et al. PLoS One. 2021 Dec 22;16(12):e0261727. doi: 10.1371/journal.pone.0261727. eCollection 2021. PLoS One. 2021. PMID: 34936686 Free PMC article. - Invariant Natural Killer T Cell Subsets-More Than Just Developmental Intermediates.
Krovi SH, Gapin L. Krovi SH, et al. Front Immunol. 2018 Jun 20;9:1393. doi: 10.3389/fimmu.2018.01393. eCollection 2018. Front Immunol. 2018. PMID: 29973936 Free PMC article. Review. - Immunoregulation of NKT Cells in Systemic Lupus Erythematosus.
Chen J, Wu M, Wang J, Li X. Chen J, et al. J Immunol Res. 2015;2015:206731. doi: 10.1155/2015/206731. Epub 2015 Dec 24. J Immunol Res. 2015. PMID: 26819956 Free PMC article. Review. - A Solvent-free Approach to Glycosyl Amides: Towards the Synthesis of α-_N_-Galactosyl Ceramides.
Chennamadhavuni D, Howell AR. Chennamadhavuni D, et al. Tetrahedron Lett. 2015 Jun 3;56(23):3583-3586. doi: 10.1016/j.tetlet.2015.02.133. Tetrahedron Lett. 2015. PMID: 26028787 Free PMC article. - Invariant natural killer T cells in lupus patients promote IgG and IgG autoantibody production.
Shen L, Zhang H, Caimol M, Benike CJ, Chakravarty EF, Strober S, Engleman EG. Shen L, et al. Eur J Immunol. 2015 Feb;45(2):612-23. doi: 10.1002/eji.201444760. Epub 2014 Nov 27. Eur J Immunol. 2015. PMID: 25352488 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases